Garcia, Gabriela,Kubasek, William,MacBeath, Gavin,Moyo, Victor
申请号：
AU2013201584
公开号：
AU2013201584A1
申请日:
2013.03.12
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013201584A120130926.pdf#####MMJ-041PC METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING AN ANTI-ERBB3 ANTIBODY 5 Abstract of the Disclosure Provided are methods for treating pancreatic cancer in a patient by co-administering combinations of an anti-ErbB3 antibody and one or more additional therapeutic agents. In one embodiment, the anti-ErbB3 antibody is co-administered with irinotecan. In another embodiment, the anti-ErbB3 antibody is co10 administered with paclitaxel (e.g., nab-paclitaxel). In a further embodiment, the anti-ErbB3 antibody is coadministered with erlotinib and gemcitabine. - 43 -
